| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb7ce8745175865c6357f7d5fe7fccf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-10022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-10034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-14143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-10061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-10051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-10021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 |
| filingDate |
1998-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a8597ee6fba8fe3b4ab408ae27ff894
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14c74adc63478c1c1711321fe731d210
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9187e16400e70cde71d7d36d08296edb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9153bb86daa3202901dbb0a2096ef028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23d155bb5d3e3588132a1e362489deba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48d99510ec142e8bb5ff033daf7e8d18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32bcc5536c677df79e6134a60dc6058c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec5fab844076b4d1decbcee8d8e28ff6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c293d42e777e1ed7a91ee0865f6c7930
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_525b35a0e593d5adeedb9cec2a2aa2b7 |
| publicationDate |
2012-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2317679-T5 |
| titleOfInvention |
VACCINAL COMPOSITION PREPARED FROM SEQUENCES OF TYPE B CIRCOVIRUS ASSOCIATED WITH THE DISEASE OF MILK SLOWING (MAP). |
| abstract |
Compound for use as a vaccine, characterized in that said compound is selected from the following compounds: <br /> <br /> a) a nucleotide sequence that has at least 80% identity with the sequence SEQ ID No. 12, and corresponding to the ORF''2 of a type B genomic sequence MAP circovirus SEQ ID No. 9 which presents variations related to mutations within the type B MAP circovirus strains, this nucleotide sequence comprising at least 80% identity with the sequence SEQ ID No. 12 at least the nucleic sequence encoding the polypeptide sequence SEQ ID No. 17, with the exception: - of the nucleotide sequences described in the international patent application published on 15 April 1999 with the number WO 99/18214 called COL13 of the type II circovirus strain IMP1011-48121 sequence: Sequence of the PCV isolate Imp1011-48121 ** see formula ** and IMP1011-48285 strain sequence: ** v er formula ** <br /> <br /> b) a sequence polypeptide that has at least 80% identity with the sequence SEQ ID No. 15 and that corresponds to a polypeptide encoded by the ORF''2 of a circovirus Type B MAP of genomic sequence SEQ ID No. 9 which shows variations related to mutations within the MAP B circovirus strains, this sequence polypeptide comprising at least 80% identity with the sequence SEQ ID No. 12 at least the polypeptide of sequence SEQ ID No. 17, with the exception: - of the polypeptides encoded by the nucleotide sequences called COL13 of the type II circovirus strain IMP1011-48121 and IMP1011-48285 whose sequences are described in a ); <br /> <br /> c) a vector or a viral particle comprising a nucleotide sequence as defined in a); or <br /> <br /> d) a cell transformed by a vector or a viral particle comprising a nucleotide sequence as defined in a). |
| priorityDate |
1997-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |